The Supervisory Board of Mirnext is composed of seasoned life-science professionals with extensive experience in setting up, managing and guiding start-up companies. The Supervisory board oversees the strategic, organizational policy making and operational activities of the Management Board.
Harm de Vries
Board member - Harm de Vries is partner at the Life Sciences Fund Amsterdam. Harm has worked for over 9 years in the biotechnology venture capital industry and has gained extensive experience in structuring, establishing, and monitoring venture capital transactions. Harm started his career as an attorney at law at an international law firm in Amsterdam and was admitted to the Amsterdam bar association in 1995. Harm holds a masters degree in business law from the Erasmus University of Rotterdam, the Netherlands.
Board member - Marcel Kloosterman, PhD has worked for DSM since 1985 in various functions ranging from market research and business development to new business creation before joining DSM Venturing. His fields of interest and expertise span the areas of Life Sciences, Performance Materials and Clean Tech. Since 2006 he has been investment manager for Limburg Ventures, where he holds several board positions in portfolio companies. Since 2010 Marcel is also active as investment manager for Nedermaas High Tech Ventures and in various European advisory boards.